GSK3beta is involved in JNK2-mediated beta-catenin inhibition

Dong Hu1, Xiuli Bi, Wenfeng Fang

  • 1Department of Pathology, University of Illinois at Chicago, Chicago, Illinois, United States of America.

Plos One
|August 14, 2009
PubMed
Abstract

Insights

Mitogen-activated protein kinase (MAPK) JNK2 suppresses beta-catenin signaling, similar to JNK1. This interaction, crucial for intestinal homeostasis and tumor suppression, involves glycogen synthase kinase 3 beta (GSK3beta).

Area of Science:

  • Cellular Biology
  • Molecular Biology
  • Oncology

Background:

  • Mitogen-activated protein kinase (MAPK) JNK1 was previously shown to downregulate beta-catenin signaling.
  • JNK1 plays a critical role in intestinal homeostasis and tumor suppression.
  • The function of the related MAPK, JNK2, in beta-catenin signaling regulation was investigated.

Purpose of the Study:

  • To determine if JNK2 has similar or different functions compared to JNK1 in regulating beta-catenin signaling.
  • To elucidate the molecular mechanisms underlying JNK2's regulation of beta-catenin.

Main Methods:

  • In vitro studies involving manipulation of JNK2 and beta-catenin expression.
  • Use of proteasome and GSK3beta inhibitors (MG132, lithium chloride).
  • In vivo studies using JNK2 knockout mice and various biochemical assays (immunoprecipitation, mammalian two-hybridization, confocal microscopy).

Main Results:

  • Activated JNK2 increased GSK3beta activity, inhibiting beta-catenin expression and transcriptional activity.
  • JNK2-mediated beta-catenin downregulation was dependent on proteasome activity and GSK3beta.
  • JNK2 deficiency in mice led to beta-catenin upregulation and increased GSK3beta phosphorylation in intestinal cells.
  • Physical interaction and co-localization of JNK2, beta-catenin, and GSK3beta were confirmed.

Conclusions:

  • JNK2, like JNK1, interacts with and suppresses beta-catenin signaling both in vitro and in vivo.
  • Glycogen synthase kinase 3 beta (GSK3beta) plays a key role in JNK2-mediated beta-catenin suppression.
  • The findings reveal a novel crosstalk between Wnt/beta-catenin and MAPK JNK signaling pathways.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
Catenins01:23

Catenins

Catenins are characterized by multiple binding domains and dynamic structures that allow them to function as linker proteins in cell junction complexes. All catenins, except α-catenin, contain a characteristic protein sequence called the armadillo repeat and are therefore also called armadillo proteins.
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the adherens...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...